I guess [Eliquis] results are on an ITT basis but we'll know that by Aug. as well.
The efficacy data for superiority relative to warfarin are on a strict ITT basis. The safety (bleeding) data are modified ITT, including all patients who received at least one dose.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”